BREATH-EASY COPD Trial

Study Overview

A completed study that evaluated a dual bronchodilator combination inhaler for maintenance treatment of COPD. The study demonstrated significant improvements in lung function and quality of life.

Inclusion Criteria

• ✓Adults aged 40-80 years
• ✓Moderate to severe COPD
• ✓Current or former smoker
• ✓FEV1 30-70% predicted

Exclusion Criteria

• ✗Asthma diagnosis
• ✗COPD exacerbation within 6 weeks
• ✗Long-term oxygen therapy
• ✗Unstable cardiac disease